Company: SNWV
Filing Date: 2025-03-06
Form Type: 8-A12B
Source: 0001628280-25-010972
Chunk: 1

Company: SANUWAVE Health, Inc.
Filing Date: 2025-03-06
Form: 8-A12B
Chunk 1
---
 Nasdaq Stock Market LLC (“Nasdaq”). The Company expects the listing and trading of its Common Stock on the OTCQB to cease on the close of trading on March 6, 2025, and that listing will be effective and trading of its Common Stock will begin on Nasdaq at market open on March 7, 2025.

## Item 1. Description of Registrant’s Securities to be Registered.
The description of the Common Stock of the Company included in Exhibit 4.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission on March 21, 2024, is incorporated herein by reference, except that the reference to the OTCQB included therein is hereby amended to refer to Nasdaq.

## Item 2. Exhibits.
Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the Company are listed on Nasdaq and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

### SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

| Dated: March 6, 2025 |     | SANUWAVE HEALTH, INC. 
 By:                   |     | /s/ Peter Sorensen      |
|:---------------------|:----|:----------------------|:----|:------------------------|
|                      |     | Name:                 |     | Peter Sorensen          |
|                      |     | Title:                |     | Chief Financial Officer |